Kmsantosh

What if, for example, we could use a phone app to provide the consumer the power to literally take charge of expedited shipment? Now, we could use an app to find the individual, ship, and when they got there, ship to both the person and the service. It may occasionally only be accessible through programs. Like you do now, we will still be able to forward freight to other sites. We might still ship and provide services to establishments and other places. We can give you information on the shipping, but they will handle it. Among other reasons, this is the main reason we're starting with expedi

According to Biomedicine Today, Amgen (AMGN) will provide Temodar, a drug used to treat multiple sclerosis (MS), to India for the first time. MS is the primary supplier of cancer drugs in India, accounting for two thirds of all cancer treatments rendered in the nation. MS is the second-largest source. Along with other biopharma shipments from Amgen's Indian partner Cipla, Novartis, a partner of Amgen, also supplies the MS drug to India. The two large pharmaceutical corporations declared their ambition to work together in 2014.